Constructing a Novel Prognostic Signature Based on TGF-β Signaling for Personalized Treatment in Pancreatic Adenocarcinoma

Figure 5

Univariate (a) and multivariate (b) cox regression analysis of the 7-gene signature and other clinical features. HR, hazard ratio. CI, confidence interval. (c) Gene set enrichment analysis of hallmark pathways of each sample ranking by risk score in TCGA-PAAD dataset. ES, enrichment score. NES, normalized enrichment score. FDR, false discovery rate.

(a)

(b)

(c)